Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Total Assets 2019–2025
Recursion Pharmaceuticals, Inc. annual total assets history from 2020 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Recursion Pharmaceuticals, Inc. total assets as of December 31, 2025: 1.47B, a 1.76% increase year-over-year.
- Recursion Pharmaceuticals, Inc. total assets for 2025 were 1.47B, a 1.76% increase from 2024.
- Recursion Pharmaceuticals, Inc. total assets for 2024 were 1.45B, a 121.60% increase from 2023.
- Recursion Pharmaceuticals, Inc. total assets for 2023 were 653.7M, a 6.79% decrease from 2022.
- Recursion Pharmaceuticals, Inc. total assets for 2022 were 701.3M.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Recursion Pharmaceuticals, Inc. Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $1,474 |
| 2024 | $1,449 |
| 2023 | $654 |
| 2022 | $701 |
| 2021 | $610 |
| 2020 | $299 |
Recursion Pharmaceuticals, Inc. Total Assets — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) total assets over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXRX's total assets history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s total assets by year and by quarter, including the growth rate.